Chemotherapy, Radiation Therapy, and Nasopharyngeal Carcinoma—Reply
Author:
Affiliation:
1. Department of Radiation Oncology, Affiliated Hospital of Guilin Medical University, Guilin, China
2. Key Laboratory of Oncology (Guilin Medical University), Education Department of Guangxi Zhuang Autonomous Region, Guilin, China
Publisher
American Medical Association (AMA)
Link
https://jamanetwork.com/journals/jamaoncology/articlepdf/2821032/jamaoncology_dai_2024_lr_240014_1719947214.27708.pdf
Reference6 articles.
1. Induction chemotherapy followed by radiotherapy vs chemoradiotherapy in nasopharyngeal carcinoma: a randomized clinical trial.;Dai;JAMA Oncol,2024
2. Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG) 1303 Study.;Hong;Ann Oncol,2018
3. Once-a-week versus once-every-3-weeks cisplatin chemoradiation for locally advanced head and neck cancer: a phase III randomized noninferiority trial.;Noronha;J Clin Oncol,2018
4. Prognostic value of the cumulative cisplatin dose during concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a secondary analysis of a prospective phase III clinical trial.;Peng;Oncologist,2016
5. Exploratory study of NPC-0501 trial: optimal cisplatin dose of concurrent and induction/adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma.;Ng;Clin Cancer Res,2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3